CN1069969A - 作为兴奋性氨基酸神经递质拮抗剂的合成芳基多胺 - Google Patents

作为兴奋性氨基酸神经递质拮抗剂的合成芳基多胺 Download PDF

Info

Publication number
CN1069969A
CN1069969A CN92109681A CN92109681A CN1069969A CN 1069969 A CN1069969 A CN 1069969A CN 92109681 A CN92109681 A CN 92109681A CN 92109681 A CN92109681 A CN 92109681A CN 1069969 A CN1069969 A CN 1069969A
Authority
CN
China
Prior art keywords
boc
polyamines
compound
gram
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN92109681A
Other languages
English (en)
Chinese (zh)
Inventor
N·A·萨科曼诺
R·A·福克曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire NPS Pharmaceuticals Inc
Pfizer Inc
Original Assignee
Pfizer Inc
NPS Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, NPS Pharmaceuticals Inc filed Critical Pfizer Inc
Publication of CN1069969A publication Critical patent/CN1069969A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
CN92109681A 1991-08-23 1992-08-22 作为兴奋性氨基酸神经递质拮抗剂的合成芳基多胺 Pending CN1069969A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74901491A 1991-08-23 1991-08-23
US749,014 1991-08-23

Publications (1)

Publication Number Publication Date
CN1069969A true CN1069969A (zh) 1993-03-17

Family

ID=25011863

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92109681A Pending CN1069969A (zh) 1991-08-23 1992-08-22 作为兴奋性氨基酸神经递质拮抗剂的合成芳基多胺

Country Status (14)

Country Link
EP (1) EP0641312A1 (cs)
JP (1) JPH06505996A (cs)
CN (1) CN1069969A (cs)
AU (1) AU2426392A (cs)
BR (1) BR9206403A (cs)
CA (1) CA2114798A1 (cs)
CZ (1) CZ39994A3 (cs)
FI (1) FI940833A7 (cs)
HU (1) HU9400503D0 (cs)
IL (1) IL102835A0 (cs)
MX (1) MX9204866A (cs)
PT (1) PT100801A (cs)
WO (1) WO1993004036A1 (cs)
ZA (1) ZA926314B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en) 1993-02-08 2001-04-03 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6750244B2 (en) 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE69434889D1 (de) 1994-02-08 2007-01-11 Nps Pharma Inc An einer neuen Stelle von Rezeptorabhängigen Kalziumkanälen wirkende Verbindungen zur Behandlung von neurologischen Erkrankungen
US20010004460A1 (en) * 1995-06-08 2001-06-21 Carla Rasmussen Klittich Process for the preparation of rice seed for sowing
US8198334B2 (en) 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
AU2003231670B2 (en) * 1997-10-27 2006-06-08 Slil Biomedical Corporation Methods for modulating macrophage proliferation using polyamine analogs
US7087648B1 (en) 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
IL146126A0 (en) 1999-04-30 2002-07-25 Slil Biomedical Corp Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
US20030130356A1 (en) 2001-10-16 2003-07-10 Slil Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
JP2007505044A (ja) * 2003-09-09 2007-03-08 ユニバーシティ オブ フロリダ リサーチ ファウンデイション、インコーポレイテッド ポリアミン−金属キレーター接合体
CN103073448B (zh) * 2012-12-29 2015-11-18 河南大学 含芳环结构的多胺衍生物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Also Published As

Publication number Publication date
MX9204866A (es) 1993-04-01
FI940833A0 (fi) 1994-02-22
EP0641312A1 (en) 1995-03-08
CA2114798A1 (en) 1993-03-04
CZ39994A3 (en) 1994-11-16
ZA926314B (en) 1994-02-21
WO1993004036A1 (en) 1993-03-04
FI940833L (fi) 1994-02-22
IL102835A0 (en) 1993-01-31
PT100801A (pt) 1993-09-30
FI940833A7 (fi) 1994-02-22
JPH06505996A (ja) 1994-07-07
HU9400503D0 (en) 1994-05-30
BR9206403A (pt) 1994-12-27
AU2426392A (en) 1993-03-16

Similar Documents

Publication Publication Date Title
CN1231478C (zh) 光学活性的哌啶中间体的制备方法和该中间体
CN1216864C (zh) 烟碱性受体激动剂的正调节剂
CN1083431C (zh) 新的杂环化合物
CN1069969A (zh) 作为兴奋性氨基酸神经递质拮抗剂的合成芳基多胺
CN1688544A (zh) 作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6－二取代的氮杂双环(3.1.0)己烷衍生物
CN101039908A (zh) 作为11－β羟甾类脱氢酶抑制剂的三环内酰胺衍生物
CN1131144A (zh) 甘氨酰胺衍生物及其制法和含有它们的药物
CN1069309C (zh) N-(-氨基丙基)n-苯基-5,6,7,8-四氢化萘-2-羧酰胺衍生物、制法及应用
CN1236367A (zh) 为支气管治疗药物的苯并萘啶
CN1681779A (zh) 4－吡咯烷基－苯基－苄基醚衍生物
CN1620290A (zh) 作为5－羟色胺－6配体的吲哚基烷基胺衍生物
CN1062729A (zh) 可用作血管紧张肽转化酶抑制剂的含氨基和硝基的三环新化合物
CN1227544A (zh) 作为兴奋性氨基酸拮抗剂的四氢喹啉衍生物
CN1055537A (zh) 3，5-双取代-2-异唑烷和异唑、其制备方法，含有该成分的制剂及其应用
CN1095712A (zh) 四氢咔唑衍生物
CN1071915A (zh) 作为兴奋性氨基酸神经传递素拮抗药的合成杂芳基多胺
CN1926098A (zh) 新的脲衍生物及其医药应用
CN1034366A (zh) 非肽的血管紧张肽原酶抑制剂
CN1025334C (zh) 新的谷氨酸衍生物的制备方法
CN1208333C (zh) 主要用于治疗骨质疏松的吲哚衍生物
CN1037510C (zh) 制备吲哚衍生物的方法
CN1135216A (zh) 光学活性咪唑烷酮衍生物及其制造方法
CN1188111A (zh) 4－羟基－哌啶衍生物
CN1282322A (zh) 1,4－二氮杂环庚烷衍生物
CN1252049A (zh) 2－取代的苯甲酰基－环烷基－1－羧酸衍生物

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication